Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.

Anabolic androgenic steroids (AAS) are a class of steroid hormones related to the male hormone testosterone. They are frequently detected as drugs in sport doping control. Being similar to or derived from natural male hormones, AAS share the activation of the androgen receptor (AR) as common mechanism of action. The mammalian androgen responsive reporter gene assay (AR CALUX bioassay), measuring compounds interacting with the AR can be used for the analysis of AAS without the necessity of knowing their chemical structure beforehand, whereas current chemical-analytical approaches may have difficulty in detecting compounds with unknown structures, such as designer steroids. This study demonstrated that AAS prohibited in sports and potential designer AAS can be detected with this AR reporter gene assay, but that also additional steroid activities of AAS could be found using additional mammalian bioassays for other types of steroid hormones. Mixtures of AAS were found to behave additively in the AR reporter gene assay showing that it is possible to use this method for complex mixtures as are found in doping control samples, including mixtures that are a result of multi drug use. To test if mammalian reporter gene assays could be used for the detection of AAS in urine samples, background steroidal activities were measured. AAS-spiked urine samples, mimicking doping positive samples, showed significantly higher androgenic activities than unspiked samples. GC-MS analysis of endogenous androgens and AR reporter gene assay analysis of urine samples showed how a combined chemical-analytical and bioassay approach can be used to identify samples containing AAS. The results indicate that the AR reporter gene assay, in addition to chemical-analytical methods, can be a valuable tool for the analysis of AAS for doping control purposes.

[1]  A. Kortenkamp,et al.  Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. , 2002, Environmental science & technology.

[2]  S. Loewe,et al.  Über Kombinationswirkungen , 1926, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.

[3]  E. M. de Groene,et al.  Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. , 2001, Analytical biochemistry.

[4]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[5]  C. Tohyama,et al.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Bart Van der Burg,et al.  Detection of multiple hormonal activities in wastewater effluents and surface water, using a panel of steroid receptor CALUX bioassays. , 2008, Environmental science & technology.

[7]  W. Schänzer,et al.  Metabolism of anabolic androgenic steroids. , 1996, Clinical chemistry.

[8]  Harm Kuipers,et al.  Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.

[9]  B. Térouanne,et al.  Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results , 2002, Molecular and Cellular Endocrinology.

[10]  Shin-ichi Sakai,et al.  Brominated dioxin-like compounds: in vitro assessment in comparison to classical dioxin-like compounds and other polyaromatic compounds. , 2003, Environment international.

[11]  D. Catlin,et al.  Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. , 2002, Rapid communications in mass spectrometry : RCM.

[12]  L. Gray,et al.  A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  G. Greendale,et al.  Circulating bioactive androgens in midlife women. , 2006, The Journal of clinical endocrinology and metabolism.

[14]  Tetrahydrogestrinone is a potent androgen and progestin. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  Abraham Brouwer,et al.  Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  R. K. Meyer,et al.  Myotrophic Activity of 19-Nortestosterone and Other Steroids Determined by Modified Levator Ani Muscle Method.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  C. Portier,et al.  Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.

[18]  B. van der Burg,et al.  4-Hydroxytamoxifen Trans-Represses Nuclear Factor-κB Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER)α, and Not through ERβ. , 2001, Endocrinology.

[19]  Keesook Lee,et al.  Novel yeast bioassay system for detection of androgenic and antiandrogenic compounds. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  Andrew J. Hutt,et al.  Recent Advances in Doping Analysis , 2002 .

[21]  M. Blankenstein,et al.  Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen , 1988, Journal of cellular physiology.

[22]  W. Schoonen,et al.  Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  Yu-Chen Chang,et al.  Tetrahydrogestrinone: discovery, synthesis, and detection in urine. , 2004, Rapid communications in mass spectrometry : RCM.

[24]  F. Orio,et al.  A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects , 2000, Molecular and Cellular Endocrinology.

[25]  Francesco Botrè,et al.  Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro models to study effects and mechanisms. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[26]  David Handelsman,et al.  Structure–activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  M. Lamoree,et al.  Biological validation of a sample preparation method for ER-CALUX bioanalysis of estrogenic activity in sediment using mixtures of xeno-estrogens. , 2006, Environmental science & technology.

[28]  J. Sumpter,et al.  Several environmental oestrogens are also anti-androgens. , 1998, The Journal of endocrinology.

[29]  Willem G Schoonen,et al.  Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[31]  Anna Petersson,et al.  Pharmacoepidemiology of anabolic androgenic steroids: a review , 2005, Fundamental & clinical pharmacology.

[32]  M. Nielen,et al.  Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. , 2006, Analytical chemistry.

[33]  I. Huhtaniemi,et al.  Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  E. Marshall.  The drug of champions. , 1988, Science.

[35]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[36]  G. Jenster,et al.  Molecular basis of androgen insensitivity , 1996, Steroids.

[37]  Takahiro Matsumoto,et al.  Late onset of obesity in male androgen receptor-deficient (AR KO) mice. , 2003, Biochemical and biophysical research communications.